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ABSTRACT 
 
Systematic Approach to Compare the Inflammatory Response  
of Liver Cell Culture Systems Exposed to Silver, Copper,  
and Nickel Nanoparticles. (August 2010) 
Nivedita Banerjee, B.S., University of Calcutta; 
M.Sc., Bangalore University, India 
Chair of Advisory Committee: Dr. Christie M. Sayes 
 
Although nano-sized metal colloids are used in industrial and medicinal 
applications, little is known about the potential liver toxicity of these materials 
after occupational or intentional exposures. To begin to resolve some 
outstanding hepatotoxicity concerns, the inflammatory response of hepatocytes 
after exposure to metal colloids was assessed. Four ~30-nm-sized metal 
colloids, including silver (nano-Ag), copper (nano-Cu) and nickel (nano-Ni) were 
examined in an effort to understand the induced cytokine expression in a murine 
liver cell line (AML12). Here we also utilized another system, co-cultures of 
hepatocytes, Kupffer’s cells, and lymphocytes isolated from C57BL6 mice. Cells 
were exposed to the materials over dose-response (0.1mg/L to 1000mg/L) and 
time-dependent (4 h, 48 h, and 1-week) studies. Cytotoxicity was measured via 
metabolism of resazurin and validated via MTT assay and cell counts. 
Inflammatory response was determined by cytokine profiles (TNF-α and IL-6), as 
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well as by mRNA and protein expression of heat shock protein (Hsp70). Results 
from cells exposed to nano-Ag to doses of up to 100mg/L exhibited no 
significant changes in cytotoxicity, IL-6, or TNF-α production, or Hsp70 
expression. Both nano-Cu and nano-Ni exposed cells exhibited decreased 
metabolism, increased Hsp70 induction, and increased inflammatory responses 
(IL-6 and TNF-α). Dynamic light scattering and electron microscopy were used 
to characterize particle size and surface charge. All three metal colloidal 
systems demonstrated different particle size distributions, agglomerated sizes, 
and surface zeta potentials. Furthermore, each metal colloid system elicited 
different inflammatory biomarker responses and stress protein expression. 
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1. INTRODUCTION 
1.1 Industrial applications of metal nanoparticles  
1.1.1 Nanoparticles 
The word “nano” (derived from Greek word meaning extremely small) is a 
prefix indicating a measurement of one-billionth of a standard measurement (or 
10-9 m). A nanoparticle is a cluster of atoms having an amorphous or crystalline 
structure, with at least one dimension measuring less than 100 nm. Due to their 
small size, these particles exhibit properties remarkably different from their bulk 
counterparts of identical chemical composition. Here, bulk counterpart refers to 
the micro (100–10,000 nm) or macro (>10,000 nm) size scale of the material 
with identical chemical, crystalline, and impurity composition when compared 
with the nanoparticle counterpart. 
The unique set of physical and chemical properties (namely optical, 
electrical, magnetic, and catalytic properties) exhibited by nanoparticles has 
attracted universal interest among scientists and engineers to explore their use 
for promising applications such as drug delivery and novel composites. 
(Alivisatos, 1996; Crooks, 2001; Katz and Willner, 2004; Rosi and Mirkin,  2005). 
As the particle size shifts from the micro to the nano scale, the increased fraction 
of atoms at the surface of the particle allows interactions of the surface atoms to 
assume a larger role than that of interior atoms. 
_____________ 
This thesis follows the style of Toxicology Letters.   
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The interactions of the surface atoms determine the characteristics of the 
particle.  
As an illustration, a nanoparticle with a diameter a thousand times smaller 
than its micro-sized counterpart will also have approximately one-thousand-fold 
enhanced reactivity than the microparticle (Buzea et al., 2007). Accordingly, the 
ability to tune the particle size allows greater control of interfacial characteristic, 
such a reactivity. Additionally, quantum effects resulting from of a particle’s 
discontinuous movements from quantum confinement distinguish nanoparticles 
from microparticles. These factors affect the particle surface reactivity, 
mechanical motions, optical and electrical properties, and magnetism (Buzea et 
al., 2007).  
1.1.2 Metal nanoparticles 
Metal nanoparticles possess outstanding optical and dielectric (high 
polarizability) properties. Metal nanoparticles have proven to be the primary 
building block of the next generation of multifunctional nanomaterials. These 
inorganic particles can be surface functionalized, chemically modified, and easily 
synthesized. There are various examples of metal nanoparticles, including silver, 
gold, copper, nickel, and zinc.  
1.1.3 Types of metal nanoparticles 
Metal-based nanoparticles can generally be classified in three types, as 
shown in Fig. 1 
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Fig. 1 Types of metal nanoparticles. Metal nanoparticles are include nano-sized metal 
particles, semiconductors, and oxides of nano-sized metal made of. Examples of nano 
metals particles are silver, copper, and nickel. Quantum dots are examples of 
semiconductor nanoparticles. Examples of metal oxide nanoparticles are iron oxide and 
titanium oxide. 
 
 
One important application of iron nanoparticles is removing contaminants, 
such as chlorinated organic solvents and organochlorine pesticides, from 
groundwater, soil, and sediments. (Zhang, 2003; Nurmi, 2005). Iron 
nanoparticles are also used in sensor and transducer applications due to their 
magnetic properties. Sensors are devices which detect or quantitatively measure 
physical parameters, such as temperature and pressure. Transducers convert 
one form of energy to another form of energy; for example, a microphone 
converts sound energy into electrical signals. Magnetic nanoparticles have a 
number of biomedical applications, such as magnetic separation of biological 
materials (Kruis et al., 1998; Huber, 2005). The process of separating out 
specific biological entities from their native environment is facilitated by the 
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preparation of concentrated samples. This is achieved through a two-step 
process involving cell labeling with magnetic nanoparticles in first step and 
separating out the labeled cell using magnetic separation device in second step 
(Pankhurst, et al., 2009).  
Zinc nanoparticles, having a high selectivity property, are used industrially 
as a catalyst. Selectivity property of a catalyst is the amount of reactant 
converted into useful product; in other words, a catalyst with good selectivity will 
maximize production of useful products and minimize production of undesired 
products. Zinc nanoparticles have high anti-corrosive, anti-bacterial, and anti-
fungal properties useful in the coatings, bandages, plastic and textile industries 
(Revina, et al., 2007). 
Gold nanoparticles, with unique plasmon-resonant optical scattering 
properties, are widely used in cellular imaging, drug delivery, and other 
biomedical applications (Wangoo et al., 2008). Surface plasmons are surface 
electromagnetic waves that propagate in a direction parallel to the metal surface. 
The excitation of surface plasmons by light is used to enhance surface 
sensitivity, such as that of fluorescence, for spectroscopic measurements. The 
most important and useful features of gold nanoparticles are lack of 
photobleaching, ease in synthesis, and stability in various suspension media 
(Chithrani et al., 2006; J. M. Klostranec and Chan, 2006; Chithrani and Chan, 
2007). The image in Fig. , obtained from a transmission electron micrograph 
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(TEM), depicts the spherical shape of gold nanoparticles. Fig. 3 shows a 
schematic representation of the gold nanoparticle synthesis procedure. 
 
 
Fig. 2.Transmission electron microscopy image of gold nanoparticles. The point 
resolution is 2.7A and operation voltage is 200kV.The camera used was Gatan Tridiem 
GIF-CCD (2kx2k CCD camera). TEM grids were prepared by adding 2 µL of 
synthesized nanomaterial onto the copper grid surface (carbon-coated 400 mesh). 
(Image was taken by Banerjee and Sayes with the aid of Kim & Holzenburg, MIC, 
TAMU.) 
 
 
 
Fig. 3. Schematic representation of gold nanoparticle synthesis. 
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Another set of metal nanoparticles, quantum dots, are semiconductors 
exhibiting promising industrial uses, including LEDs (light emitting diodes), 
lasers, and telecommunication devices, such as optical amplifiers. Quantum 
dots are also known as nanocrystalline semiconductors. A semiconductor is a 
material with electrical conductivity between that of an insulator and a conductor. 
Modern day electronics are heavily dependent upon advanced semiconductors.  
Through controlled tuning of the size and shape of a quantum dot, one 
can tailor the characteristics of a quantum dot for a desired application, such as 
a biosensor. Current biosensors use fluorescence-based dyes that limit them to 
a small number of colors as they emit light across a broad spectral width. In 
contrast, quantum dots can be fine tuned to emit at different wavelengths simply 
by altering the size of the dot (Wuister, et al., 2004). Electrical conductivity of a 
semiconductor can be influenced by an external stimulus, such as voltage or 
light. This property of semiconductors is used to advantage in electrical circuits 
and optical applications (EU-OSHA – European Agency for Safety and Health at 
Work. 2009). Fig. 4 shows quantum dots used as single electron transistor in 
various electronic industries  (Michalet, et al., 2005; Xing, et al., 2009). 
Metal oxide nanoparticles have proven to be useful for a variety of 
applications, including catalysis, sensors, and optical-electronics. Oxides of 
different metals, like titanium oxide (TiO2) nanocrystal, are the main component 
of paint, pigments, and cosmetics. These particles can also be used to remove 
pollutants from air and water and sterilize polluted items (Kominami et al., 2000). 
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Iron oxide nanoparticles can be used for molecular imaging. Antibodies have 
been coupled with iron oxide nanoparticles and tested in vitro or in vivo (Kruis, et 
al., 1998; Huber, 2005). Zinc oxide nanoparticles have a unique set of 
mechanical and other physical properties. With the combination of a high melting 
point and high stability, zinc oxide nanoparticles have potential applications in 
various fields of modern technologies, such as in capacitors, photo-printing, and 
ceramic devices (Singbal, et al., 1997; Dem’yanets, et al., 2006). Transparent 
zinc oxide nanoparticles are used in the forestry and paper products industry as 
functional coatings to protect wood, paper, plastics, and textiles from ultraviolet 
radiation and microbial degradation. 
 
 
Fig. 4.Computerized representation of a GaAs quantum dot. Electron charge density 
(indicted by green) around atomic gallium nucleus (indicated by purple) for gallium 
arsenide containing 465 atoms (Cartoixa, X., and Wang, L.W., 2005.) 
(http://www.lbl.gov/Science-Articles/Archive/Quantum-Dot Electronics.html). 
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1.2 Mass-produced metal nanoparticles in industry 
The increase in production of nanoparticles intended for different 
industrial and consumer applications also presents new risks and uncertainties 
to both human health and the environment. Growing mass production and 
increasing consumer use of nanoparticles result in a mounting number of 
workers and consumers exposed to nanoparticles. This leads to the need for an 
understanding of the possible fate, transport, and environmental effects on 
human health and the environment after exposure to nanoparticles. In our study, 
we have identified three different nanoparticles that have significant industrial 
applications.  
1.2.1 Nanosilver 
Silver nanoparticles have been proposed to be used as an antimicrobial, 
antibacterial, and antifungal agent (Antimicrobial agent is a general term for 
substances, chemicals, or drugs which either kill or reduces the growth of 
microorganisms such as bacteria and fungi)  (Chen and Schluesener, 2008). 
Silver nanoparticles are extensively applied in medical applications like wound 
dressing, bandages, and in surgical tools. Surgical mesh coated with 
nanocyrstalline silver particles are used to reduce the prosthetic mesh infections 
after hernia and pelvic surgery (Arora et al., 2009). Silver nanoparticles, due to 
their antimicrobial properties, are used in household items like nanosilver-lined 
refrigerator seals, washing machine seals, washing detergents, and air-
conditioner filters. Nanosilver particles are also used in clothing like footwear 
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and socks. They are also used in personal care products such as cosmetics, 
shampoos, and conditioners (EU-OSHA, 2009). Silver nanoparticles are also 
used in wastewater treatment and maintenance of indoor air quality (Chen and 
Schluesener, 2008). Due to high conductivity of silver nanoparticles, they can 
also be used as coatings in the form of glues, inks, paste and other polymers. 
Nanosilver particles are currently used to make thinner pastes and coatings as 
opposed to what was previously made from silver powder (EU-OSHA, 2009). 
1.2.2 Nanocopper 
Copper nanoparticles are used in industry in coatings to reduce growth of 
living organisms like fungi (Cioffi et al., 2005; Lei et al., 2008) and as a highly 
reactive catalyst in organic reactions. Due to their excellent mending properties, 
copper nanoparticles can be used as additives in lubricants, polymers, and 
plastics to reduce friction. (Liu, et al.,  2004).  Studies have also shown to 
improve charge-discharge properties, copper nanoparticles deposited onto 
graphite can be utilized (Guo, 2002; Chen et al., 2006).  Copper nanoparticles is 
also known to inhibit the growth of microorganisms (Cioffi  et al., 2005). Copper 
nanoparticles are also used as additives in poultry and livestock feed (Lei et al., 
2008).  
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1.2.3 Nanonickel 
Nickel nanoparticles are widely used in industry due to their high surface 
energy, high surface area, high magnetism, and low melting and boiling points. 
Nickel nanoparticles are used to improve the wear-resistance and high-
temperature oxidation resistance of titanium and titanium alloys (Yi, et al., 2007). 
Nickel nanoparticles are also used in fuel cell electrodes due to their increased 
surface area and activity. The enhancement of magnetic, anti-corrosive, 
antimicrobial, and durability properties of the material is observed in coatings 
made of nickel nanoparticles. Nickel nanoparticles are also used in paints and 
as inks. Also, it has been reported that nickel nanoparticles are used in various 
filtration techniques such as gas separation, bacteria and biohazard removal, 
and in air purification.  
1.3 Occupational-based exposure and the field of exposure science  
Recently, there has been a rapid international development of companies, 
such as Auterra (previously Applied Nanoworks), PlasmaChem, OceanNanotech 
and Nanotherapeutics, producing nanoparticles and nanoparticle-based 
consumer products. It has been estimated that by 2020, roughly 2 million 
workers will be employed in nanotechnology based industries (Schulte, et al.,  
2008). These developments have drawn attention of researchers to study the 
potential health risks of workers who might be unintentionally exposed to those 
nano-sized particles. Inhalation and trans-dermal absorption  (Paul,  et al., 2006) 
can be classified as two types of occupational-based exposures. There is limited 
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epidemiological data available on occupational exposure to nanoparticles, which 
is used in exposure science. Exposure science is the study of interaction of 
chemical, physical or biological agents present in the environment with human 
body. Exposure science also advances knowledge of the mechanisms and 
dynamics of events either causing or preventing adverse health effects. 
1.3.1 Examples of occupational exposure 
Several scientists are currently working on the benefits of nanoparticle-
based products. Workers in nanoparticle-based industries are expected to be in 
direct contact with metal nanoparticles. Some of these nanoparticles have been 
proven to be toxic at certain exposure levels (Braydich-Stolle et al., 2005; 
Hussain et al., 2005; Chen et al., 2006; Hussain et al., 2006). It is expected that 
nanoparticles might become part of airborne dust if an accidental release takes 
places at a workplace. Dispersion of an accidentally released stream containing 
nanoparticles might pose a health risk to plant personnel based on level of 
exposure. Moreover, as industrial pollution increases with time, the 
concentration of nanoparticles in the air is also expected to increase. A clear 
understanding of the toxicity of these nanoparticles is therefore required to 
define the safe levels of nanoparticle exposure.  
1.3.1.1 Occupational exposure and exposure assessment of various toxic 
compounds and substances 
Working with toxic materials is expected to result in chronic occupational 
exposure of the personnel working and handling the materials. As an elaborate 
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example, occupational exposure to ethanol is described below to emphasize that 
similar effect can be expected from emerging nanotechnology based industries.  
Industrial ethanol exposure: Industrial ethanol is currently one of the 
largest volume organic chemicals produced. It is widely used in industry to 
manufacture different types of consumer products. Occupational exposure to 
ethanol mostly occurs through inhalation and dermal routes. The use of ethanol-
based products, such as antiseptic hand gels which is used as antibacterial 
agent to combat the spread of antibiotic-resistant bacterial strains, may also 
result in increased dermal exposure for both workers in industries and scientists 
in the laboratory and can act as a potential cancer risk ( Bevan et al.,  2009). 
Nanoparticles exposure: Personnel working in nanoparticle-based 
industries are exposed to different types of nanoparticles. As an example, a 
number of studies showed exposure to carbon black can lead to adverse effects 
in humans (Guo et al., 2009). It is hence important to understand and assess the 
risk associated with nanoparticle exposure. Risk assessment is the basis of 
assessing and regulating nanomaterials to protect health and the environment. 
Biological markers such as urine or blood are used to assess the exposure to 
toxic metal or chemicals. Urine can be more conveniently collected than blood. 
Urine is the most reliable and preferred indicator, as the kidney is the main 
nexus of elimination of toxic metals (e.g., zinc oxide nanoparticles, inorganic 
arsenic) or other chemicals through excretion. In addition hair is used for 
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forensic investigation of occupational exposure of toxic metal (Farmer and 
Johnson,1990).  
Occupational exposure limit values (OELs): OEL for hazardous materials 
is an important tool for health risk assessment. It also helps in managing 
valuable information for occupational safety and health activities concerning 
hazardous substances. The National Institute for Occupational Safety and 
Health (NIOSH) is the primary federal agency conducting such research and 
provides guidance on the occupational safety and health implications and 
applications of nanotechnology.  
Current safety practices: To minimize consequences from occupational 
exposure hazard, Occupational Safety and Health Administration (OSHA), has 
formulated safety standards to be followed in industries. To maintain safe 
working conditions and to prevent injury to personnel, OSHA standard 1910.9(a) 
and 1910.9(b) of 29CFR requires:  
 Personal protective equipment (PPE): Standards in this part requires the 
employer to provide personal protective equipment (PPE), including 
respirators and other types of PPE, because of hazards to employees 
impose a separate compliance duty with respect to each employee 
covered by the requirement.  
 Training: Standard in this part requires training on hazards and related 
matters should be provided to employees, or employers should institute 
or implement a training program for the same. 
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However, these OSHA standards may not address safety issues arising from 
potential nanoparticles exposure. Although the potential health effect of such 
exposure is not fully understood at this moment, OSHA, as part of a 
government-wide coordination effort, OSHA is working with other federal 
agencies like NIOSH to address issues related to the impact of nanomaterials on 
human health and the environment.   Current OSHA standards which may be 
applicable to nanoparticle exposure in workplace are 1904 (Reporting 
occupational injuries), 1910.132 (PPE), 1910.133 (Eye and face protection), 
1910.134 (Respiratory protection), 1910.138 (Hand protection), 1910.141 
(Sanitation), 1910.1200 (Hazard communication) and 1910.1450 (Occupational 
exposure to hazardous chemicals in laboratory). 
While some nanoparticles like titanium dioxide, carbon black, or nickel 
nanoparticles are handled both in industry and in the laboratory, there are newly 
synthesized nanoparticles which are manufactured and handled only at the 
laboratory scale. Toxicity of such particles is not well understood. Students or 
research scientists can be affected while working with these nanoparticles. To 
improve the working condition in laboratory some generic precaution should be 
taken derived from general safety practices: 
 nanoparticle work should be performed in a low velocity, laminar– flow 
type hood (e.g. Flow Science) to avoid inhalation of aerosols containing 
nanoparticles; 
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 protective cloths like aprons and gloves should be used to avoid contact 
of nanoparticles with the bare skin; 
 safety goggles should be worn to prevent eye exposure to nanoparticles; 
 in some cases, appropriate nasal masks should be used while working 
with nanoparticles in the laboratory.  
1.3.2 Unintentional exposures through inhalation 
Effects on health through unintentional inhalation exposure are a major 
concern. At the workplace, employees are likely to be exposed to nanoparticles 
during the production process, testing of products, transport, storage, or waste 
removal/treatment. Any accident occurring due to a system failure (or other 
reason) has the potential of releasing nanoparticles in large amounts, 
endangering not only the working personnel but also the neighboring people. 
Airborne nanoparticles can be easily dispersed and spread in environment 
(Oberdörster et. al. , 2005) 
1.3.3 Unintentional exposures through trans-dermal absorption 
Another important route of unintentional exposure in the workplace is 
through transdermal absorption. The nanoparticles present in the environment 
could be in contact with exposed skin. Because of their small size, nanoparticles 
have been shown to penetrate clothing and translocate through the dermal and 
subcutaneous layers of human and animal skin (Monteiro-Riviere, et al., 1990; 
Scott et al., 1991; Oberdörster et. al., 2005). 
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1.3.4 Consumer-based exposure 
In addition to unintentional exposure, exposure to nanoparticles can also 
occur through the usage of the nanoparticle-enabled products. Nanoparticles are 
used in personal care products, such as cosmetics and sunscreens (Colvin, 
2003). The use of these engineered nanoparticle-based products can lead to 
direct dermal exposure. Typically, consumer-based exposure routes can be 
further classified into two specific routes, namely ingestion and transdermal 
absorption. 
1.3.4.1 Intentional exposure through ingestion 
Due to the small particle size and the increase in nano-enabled devices, it 
is expected that nanoparticles will be found in the environment, including soil, 
water, and the food chain. Thus, increasing the likelihood of trace amounts of 
nanoparticles along with food and drinking water. In addition, groundwater 
remediation releases nanoparticles into the environment, soil, and water that 
may lead to direct human exposure (Boxall et al., 2007). The main likely route of 
entry of nanoparticles to the intestinal tract is through consumption of nano-sized 
food and drink supplements or via additives, such as metals, minerals, clays, or 
lipids. The potential effects of the nanoparticles on ecosystems depend not only 
on the nanoparticle characteristics but also on the amount of nanoparticles 
emitted by industry. Various companies are conducting research on 
nanoparticle-based food packaging (Boxall et al., 2007; Chaudhry et. al. 2008). 
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1.3.5 Intentional exposure through transdermal absorption 
The use of nanoparticle-based products (such as cosmetics, sunscreen, 
and other creams) can cause direct dermal exposure that is classified as an 
intentional exposure. The amount of exposure depends on the concentration of 
the nanoparticles in the cosmetic product and the frequency of use by the 
consumer. Sunscreen-grade nanoparticles mainly consists of titanium dioxide 
(TiO2) and zinc oxide (ZnO), which are used to reflect and scatter the UV light  
(Popov, et al., 2005; Nohynek, et al., 2008). ZnO and TiO2 are also used 
extensively in other cosmetic products, such as liquid and powder foundations, 
eye shadow, and blush ( Nohynek, et al.,  2008). The availability of nanoparticle-
based consumer products is increasing with time and is readily available in 
today’s market.  
1.4 Nanoparticles exposure to liver  
1.4.1 Introduction to the concepts of absorption, distribution, metabolism and 
excretion  
The engineered metal nanoparticles are subjected to a pre-clinical test 
process like absorption, distribution, metabolism and excretion (ADME) before 
their use in biomedical applications. The factors that control the ADME profile 
are not well understood. 
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1.4.1.1 ADME definition 
Absorption, distribution, metabolism and excretion influence the kinetics 
of drug distribution throughout the tissue and thus play an important role in 
pharmacology study. 
Absorption: The first step of ADME controls the bioavailability of 
compounds. The compounds first enter the blood through the process of 
absorption. Subsequently the compounds are taken up by the targeted tissue or 
cells. 
Distribution: In the next step, the absorbed compound is carried to the 
effector’s site. Most often this happens via the blood. The flow of blood facilitates 
the distribution of the compound to different organs and tissues. 
Metabolism: The majority of the compounds metabolism is carried out in 
the liver by CYP450 enzymes. During the process, the parent compound is 
converted into its metabolites. In general these metabolites are 
pharmacologically inert in nature than the parent compound.  
Excretion: The compounds along with their metabolites are removed from 
the body through the process called excretion. The organ involved in this step is 
liver. The accumulation of these compounds in the body can have adverse 
effects on metabolism. 
1.4.2 Linking ADME to the liver 
Exposure to nanoparticles can occur through water, food, cosmetics or 
drugs. The nanoparticles are able to enter the body through the inhalation 
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process, trans-dermal absorption or ingestion. These are also known to be 
potential portals of entry. Recently it has been shown that some of the metal 
nanoparticles clearly accumulate in different organs, such as liver, kidney and 
lungs (Kim et al., 2008). The nanoparticles are taken up into the targeted tissue 
or cells after distribution to different organs. Ultimately, the particulate matter 
that enters into the body might be metabolized and excreted through the liver 
(Wan et al., 1991; Pinheiro et al., 1996; Das and Buchner, 2007; Medina et al., 
2007). The hazardous nanoparticles are either excreted from the different 
organs or persist inside the body. To correlate the broad concept of ADME with 
toxicity, it is very important to understand the potential of a compound in exerting 
harmful effect on the organs. Nanoparticles are taken up into the cells through 
the process of absorption and distribution. Once the nanoparticles are absorbed 
and distributed into the cells, they come directly in contact with liver during 
metabolism. In the process, this might lead to liver toxicity. 
1.5 Liver cell toxicity 
The liver is the largest gland in the body. It is located below the 
diaphragm and is anterior to the stomach. It consists of four lobes: the right lobe 
is the largest and is far larger than the remaining three; the left lobe and two 
other smaller lobes are placed behind the right lobe. The lobes of liver are 
shown in Fig. 5. To understand the function and dysfunction of the liver it is very 
important to know the liver structure. In this section, the following topics are 
discussed:  
20 
 
1. Structure of the liver  
a. The hepatic vascular system  
b. The biliary system,  
c. The different cell types of the liver 
d. Interaction between hepatocytes and non parenchymal cells 
e. Importance of co-culture system 
2. Physiological function  
3. Drug-induced hepatotoxicity  
4. Biomarkers for liver damage  
1.5.1 Structure of the liver  
The liver is composed of numerous hexagonal lobules oriented around a 
central vein. These hexagonal lobules, known as hepatic lobules, are considered 
to be the structural unit of the liver. Portal triads located at the corners of each 
hepatic lobule contain the branch of portal vein, a hepatic arteriole and a bile 
duct. In Fig. 6, a portal vein, a hepatic arteriole, and a bile duct are illustrated in 
red, blue and green dots. Each hepatic lobule can be divided into three regions 
namely centrolobular, midzonal, and periportal. The blood enters the portal 
triads through the portal vein and hepatic artery.  
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Fig. 5. Liver structure.. (Punnoose, J.K. 2007.)  
 
 
 
 
Fig. 6. Hepatic lobules showing portal triads containing branch of artery, vein, and bile 
duct at the corner and central vein at the center of each lobule. (Bowen, R., 2004.)  
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1.5.1.1 The hepatic vascular system 
Within a liver, 75% of the blood flows in the portal vein and is classified as 
venous blood. The venous blood, returning from small intestine, stomach, 
pancreas, and spleen, ingresses into the portal vein located in the portal triads of 
the hepatic lobule. The remaining 25% of the blood in liver flows through hepatic 
artery and is known as arterial blood. The blood entering the portal triad through 
hepatic artery and portal vein is mixed as blood enters sinusoids in the liver. 
Sinusoidal blood vessels have a fenestrated epithelium. The blood mixes 
thoroughly along the cords of hepatocytes and finally flows into terminal hepatic 
venules.  
1.5.1.2 The biliary system 
The biliary system is a series of channels and ducts that conveys bile - a 
secretory and excretory product of hepatocytes - from the liver into the lumen of 
the small intestine. Hepatocytes secrete bile into the canaliculi, and those 
secretions flow parallel to the sinusoids, but in the opposite direction that blood 
flows. A scehamatic diagram of liver biliary system is shown in Fig. 7. 
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Fig. 7. The biliary system showing hepatocytes secreting bile into the canaliculi. Bile 
secretion flow is in the opposite direction than the blood flow. (Bowen, R., 2004.)  
 
 
1.5.1.3 Parenchymal and non-parenchymal liver cells (hepatocytes) 
Of the liver’s cytoplasmic mass, 70 to 80% is composed of hepatocytes. 
The remaining part of the liver is composed of non parenchymal cells. The 
hepatocytes cells are polygonal and their sides can be facing either the sinusoid 
(sinusoidal face) or neighboring hepatocytes (lateral faces). 
Heopatocytes are epithelial cells which contain the major enzymes for 
drug and xenobiotic biotransformation. These include the major phase I drug 
metabolism enzyme family of P450 and phase II enzymes such as UDP-
glucuronosyltransferase (UGT), sulfotransferase (SULT), N-acetyltransferase 
(NAT), and glutathione S-transferase (GST). Hepatocytes also contain all the 
gene regulation pathways for P450 induction. 
 
24 
 
1.5.1.4 Liver non-parenchymal cells (sinusoidal endothelial cells, Kupffer’s cells 
and hepatic stellate cells) 
Hepatic sinusoids (sinusoidal endothelial cells): These are larger 
capillaries which form channels between cords of hepatocytes. The blood 
percolates in the sinusoidal channels before it exits through the terminal vein. 
Sinusoids serve hepatocytes with the oxygen-rich blood from hepatic artery and 
the nutrient-rich blood from the portal vein.  
Kupffer’s cells: These are the specialized resident macrophages of liver 
located in the lumen of the sinusoids. They compose 80% of the fixed 
macrophages of the body. Kupffer’s cells are developed in the bone marrow. 
The main function of Kupffer’s cells is to degrade ingested particulate matters.. 
Kupffer’s cells synthesize several mediators, like cytokines, chemokines and 
help strengthen the immune response in the liver (Ramadori and Armbrust, 
2001). Kupffer’s cells are source of cytokines as shown in Fig. 8.  
Hepatic stellate cells: Ito cells are also called fat-storing cells or hepatic 
stellate cells. These cells are located in the space of Disse between endothelial 
cells and the cord of hepatocytes. Ito cells synthesize collagen as demonstrated 
in Fig. 8 and are the major site for vitamin A storage in the body. In addition, 
there are some pit cells and a lymphocyte-type cell. The pit cells are hepatic 
natural killer cells (lymphocytes) that are located in the liver sinusoids. 
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Fig. 8. Schematic of the complex cascade of toxin-evoked interactions between 
hepatocytes and sinusoidal cells. Steps of creation of a hepatotoxicity scenario could 
involve: (1) Toxin causing injury to hepatocytes; (2) Signals from the injured hepatocyte 
to Kupffer and Ito cells as a result of step (1); (3) Kupffer cell releases cytotoxins and (4) 
Collagen secretion from Ito cells.(Klaassen,2007) 
 
 
1.5.1.4 Interaction between hepatocytes and NPC (Kupffer’s cells and Ito cells) 
in response to toxin  
Kupffer cells and Ito cells showed an activated morphology after exposure 
to hepatotoxicants, as show in Fig. 8. Activated Kupffer cells secrete large 
amounts of soluble cytotoxins. Upon activation Ito cells secrets appreciable 
amount of collagen. Ito and kupffer’s cells after activation increase in number.   
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Hepatoxicity and injury due to interaction of many toxins results in exchange of 
signals between toxicant and activated Kupffer cells. 
1.5.2 Physiological functions of the liver  
The liver regulates most chemical levels in the blood and excretes a 
product called bile, which helps carry away waste products from the liver. All the 
blood leaving the stomach and intestines passes through the liver. The liver 
processes this blood and breaks down the nutrients and drugs into forms that 
are easier to use for the rest of the body. Some of the functions of liver are as 
follows: 
 carbohydrate, protein and fat metabolism; 
 production of bile, which helps carry away waste and break down fats in 
the small intestine during digestion; 
 production of cholesterol and help to carry fats through the body; 
 conversion of excess glucose into glycogen for storage (glycogen can 
later be converted back to glucose for energy); 
 processing of hemoglobin for use of its iron content; 
 conversion of poisonous ammonia to urea (urea is an end product of 
protein metabolism and is excreted in the urine); 
 clearing the blood of drugs and other poisonous substances;  
 blood clotting;  
 resisting infections by producing immune factors and removing bacteria 
from the blood; 
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 filter the harmful substance from the blood, such as alcohol;  
 storage of vitamins and minerals (Vitamins A,D, K, and B12) 
After the liver has broken down harmful substances, liver by-products are 
excreted into the bile or blood. Bile by-products enter the intestine and ultimately 
leave the body in the form of feces. Blood by-products are filtered out by the 
kidneys, and leave the body in the form of urine.  
Hepatocytes house many metabolic pathways and are comprised of 
various enzymes which play important role during the process of metabolism. 
The liver is extremely active in oxidizing triglycerides to produce energy. The 
bulk of lipoproteins are synthesized in the liver. The liver synthesizes large 
quantities of cholesterol and phospholipids. Some of these arestored with 
lipoproteins and made available to the rest of the body. The rest is excreted in 
bile as cholesterol or excreted after conversion to bile acids. Hepatocytes are 
also responsible for synthesis of most of the plasma proteins. Albumin, the major 
plasma protein, is synthesized mostly by the liver. 
1.5.3 Drug-induced hepatotoxicity 
Most drug-induced hepatotoxicity is not clearly understood (Srivastava, et 
al., 2010). As the liver is the principal site for drug metabolism, it is known to be 
the target organ for drug-induced toxicity. Drugs that are taken up inside the 
body are generally converted to biologically inactive forms and are eliminated 
out through excretion. But some of these drugs undergo biotransformation and 
are converted to active metabolites. These metabolites can interfere with cellular 
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functions and can lead to hepatoxicity (Lei et al., 2008; Mil'to and Dziuman, 
2009; Srivastava, et al., 2010). 
The liver is exposed to drugs and xenobiotics immediately after 
absorption of drugs from gastro-intestinal tract. Once the liver is exposed to 
drugs, the phase I and phase II enzymes present in the liver control the 
biotransfromation of lipophilic compounds into water soluble derivatives and are 
readily removed from the body through excretion. But certain drugs, such as 
acetaminophen (APAP) undergo biotransformation to form toxic or reactive 
metabolites ( Keisu and Andersson, 2010  ; Srivastava, et al., 2010). These toxic 
and reactive metabolites can interact with the cellular components like cellular 
protein, lipids or nucleic acids and interfere with the cellular functions like protein 
dysfunction, lipid peroxidation, DNA damage, oxidative stress or mitochondrial 
dysfunction. The toxic metabolites can also cause hepatocyte death, sinusoidal 
disorder or bile duct damage (Keisu and Andersson, 2010; Srivastava, et al., 
2010), The schematic representation of drug induced hepatotoxicity is shown in 
Fig. 9. 
1.5.4 Biomarkers for liver damage 
During clinical trials it is very important to monitor hepatic laboratory 
parameters, such as serum aminotransferases (ALT; AST) and to investigate 
their potential clinical significance as indicators of hepatotoxicity (Keisu and 
Andersson, 2010). Alanine aminotranferease (ALT) and aspartate 
aminotransferase (AST) are enzymes located in liver cells that are released into 
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the general circulation (blood) when liver cells are injured. Both ALT and ALT 
can be measured in blood as a sensitive indicator of liver cell damage and liver 
injury.  
ALT is found in large amounts in the liver. It is also found in the kidneys, 
heart, and skeletal muscle. AST is found in heart, kidney, and liver tissue. As a 
result of injury, the level of ALT and AST serum biomarker are increased. It must 
be noted that the ALT is a more specific indicator of liver inflammation than the 
AST.  
1.6. Liver cell toxicity from metal ions 
Metal nanoparticles are composed of metal ions. In a solution containing 
metal nanoparticles, the pH can vary over time, thus leading to dissociation of 
metal particles into metal ions. In such an instance, metal nanoparticles intended 
to act as particles might induce toxic effects through the release of metal ions.  
1.6.1 Silver nanoparticles dissociate into silver ions 
In the environment (i.e. air, soil, and water), silver nanoparticles do not 
remain in the nano-size regime. They can agglomerate to form larger clusters of 
silver particles. The formation of silver particle clusters reduces the surface area-
to-volume ratio. As a result, these clusters are less effective as an antimicrobial 
agent (Monteiro, et al., 2009). 
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Fig. 9. Schematic representation showing relationship between drug metabolism and 
toxicity. Accumulation of parent drug or formation of a reactive/ toxic metabolite that 
cannot be detoxified can cause toxicity. Epoxides or quinone are the reactive and toxic 
metabolites that interact with different macromolecules (such as protein, nucleic acid) 
and thus interfere with the cellular function. (An epoxide is a cyclic ether with three ring 
atoms. A quinone is a class of organic compound derived from aromatic compounds 
such as benzene by exchanging an even number of –CH= groups by –C(=O)– groups, 
with any necessary rearrangement of double bonds). 
 
 
Additionally, in this clustered form, silver particle agglomerates are non-
ionic and relatively inert to the environment and aquatic life. In the presence of a 
strong oxidizing agent (such as halides), however, silver nanoparticles can 
easily dissociate into silver ions. Numerous studies in literature have shown the 
release of silver ions from silver nanoparticles (Monteiro-Riviere, et al., 1990; 
Choi et al., 2008; Kong and Jang, 2008; Brandenberger, et al., 2010). 
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Nanocomposites (a composite material one of whose constituents has at least 
one dimension less than 100 nm) made from silver nanoparticles in a polyamide 
matrix have shown evidence of silver ion release through diffusion (Damm and  
Münstedt, 2008).  
1.6.1.1 Interaction of silver ions with micro-organisms 
Silver ions play an important role as an effective antimicrobial agent (Lok, 
et al.,  2006). Silver ions can kill or slow down the growth of a wide variety of 
yeast, fungi, viruses, and bacteria (Lansdown, 2006). According to some 
literature reviews (Hussain et al., 2005; Shin et al., 2007), free silver ions have 
two antimicrobial mechanisms. Firstly, presence of silver ions breaks the 
disulfide bonds of the bacterial proteins, an essential bacterial structure. 
Secondly, silver ions produce reactive oxygen species which kills the 
microorganism. Silver ions also inhibit cell cycle and cause cell death in bacteria 
(Bicanova and Thinschmidt, 1985; Lansdown, 2007; Shin et al., 2007; Chen and 
Schluesener, 2008). 
1.6.1.2 Interaction of silver ions with mammalian cells 
Some silver containing substances are believed to be beneficial to 
human/animal health. Mammalian cells are eukaryotic and hence display a 
strong unsusceptibility to the effects of silver, therefore allowing the use of silver 
in treating human disease (Goodman and Gilman, 1970). Human health care 
providers have used silver for diverse purposes for several thousand years 
(Bicanova and Thinschmidt, 1985). Thus, silver nanoparticles are extensively 
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applied in medical instruments and wound dressings (Arora et al., 2009). The 
use of silver nanoparticles in wastewater treatment and maintenance of indoor 
air quality is also found in literature (Chen and Schluesener, 2008). Today, forms 
of silver are found in functional products for water purification, bandages, 
algaecides (for pool water), and integrated into fabrics for medicinal benefits. 
Recently various clinical trials have been performed with silver nanoparticles. 
Examples include application of silver nanoparticles in acne treatment, oral 
rinses, and toothpaste. Although silver nanoparticles possess a broad spectrum 
of antimicrobial activity against gram-positive and gram-negative bacteria and 
fungi, silver nanoparticles are less toxic to mammalian cells (Arora et al., 2009). 
As a result, silver nanoparticles are used in various medical devices (Monteiro, 
et al., 2009). 
1.6.2 Copper nanoparticles dissociate into copper ions 
Very few studies have been performed to estimate the release of copper 
ions from copper nanoparticles. Studies have shown that copper nanoparticles 
can be effective vehicles for copper ion delivery to in vitro cultures (Kothapalli, 
and Ramamurthi, 2009).  
 
1.6.2.1 Interaction of copper ions with micro-organisms 
Nano-sized copper particles are also known to inhibit the growth of micro-
organisms (Cioffi et al., 2005). Copper metal reacts with proteins of 
microorganism by combining the -SH groups of enzymes, and this reaction leads 
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to the inactivation of the microorganism proteins. Copper nanoparticles were 
also used as an antimicrobial agent against E. coli and B. subtilis (Yoon, et al., 
2007). 
1.6.2.2 Interaction of copper ions with mammalian cells 
However, if copper intake exceeds the human tolerance level, it may lead 
to toxicity, high blood pressure, several mucosal irritations, hepatocellular 
necrosis, changes in lipid profiles, capillary damage oxidative stress and can 
even lead to death. (Zhou et al., 2009). Copper nanoparticle exhibits quite 
different sets of toxicological effects compared to its bulk counterpart (Chen et 
al., 2006; Warheit et al., 2007). The potential risks of nano-Cu particles on 
human health have been shown in various studies but the mechanism of toxicity 
has not been reported (Lei et al., 2008). 
There are several studies showing the toxicity of copper compounds. The 
target organs for the copper toxicity are liver and kidney (Lei et al., 2008). The 
damages in the liver and kidney are observed in rats exposed to a high dose of 
copper nanoparticles. As marker of liver damage there is an increase in enzyme 
aspirate aminotransferase (AST) and alanine aminotransferase (ALT) level in 
serum. Additionally renal glomerulus dysfunction and loss of kidney weight are 
also observed (Lei et al., 2008) due to nano copper toxicity. Recently, various 
proteomics and genomic studies have been widely applied in toxicological 
research to better understand the toxicity of copper nanoparticles. 
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1.6.3 Nickel nanoparticles dissociate into nickel ions 
Very few works demonstrating liberation of Ni ion from Ni nanoparticles or 
from Ni compound-based nanoparticles exist. While studying the stability of Ni 
nanoparticles, (Lefondeur, et. al., 2001) observed increase of Ni+ concentration  
by evaluating EPR spectra. Electron paramagnetic resonance spectroscopy is a 
technique for studying chemical species with one or more unpaired electrons. 
The observation was attributed to the partial decomposition of the NiRCS 
compound (Ni nanoparticles inserted in an organic matrix, supported on γ 
alumina), which acted as a catalyst in a benzene-hydrogenation reaction.  
1.6.3.1 Interaction of nickel ions with micro-organisms 
Nickel compounds (nanoNi and nickel oxides) have extensive industrial 
applications and are investigated as an antimicrobial agent (Pang, et al., 2009). 
Nickel nanoparticle coating shows photocatalytic properties and can be used as 
an antimicrobial agent (Rana, et al., 2005). Nickel is an essential nutrient for 
select microorganisms (Mulrooney, and Hausinger 2003). These select microbes 
are capable of sensing Ni ion concentration in a cell. However, precise 
mechanism of interaction of these microbes with Ni ion is still unknown and 
requires further investigation (Mulrooney, and Hausinger 2003). Effect of nickel 
ion concentrations on microbial populations has also been studied (Ashley, 
1982). The authors attributed starch hydrolysis to increased nickel ion 
concentration. The dissolved nickel was found to be hostile to the methanogenic 
process.   
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1.6.3.2 Interaction of nickel ions with mammalian cells 
Nickel compounds (nano-Ni and nickel oxides) are known to be very toxic 
nanoparticles. Toxicity caused by nickel is dependent on route of exposure and 
also on metabolism of these nickel particles. A number of studies have shown 
hepatic toxicity associated with nickel exposure (Coogan et al., 1989). Metallic 
nickel nanoparticles cause higher cytotoxicity and apoptosis than its micro size 
counterpart (Zhao et al., 2009).  
Consumption of nickel compounds leads to environmental and human 
health hazards. Metallic nickel particles are known to cause apoptosis, but the 
mechanism of the cell death induced by this metallic particle is yet to be 
understood (Zhao et al., 2009). The toxicological effect of nickel nanoparticles 
and metallic nickel is shown to be significantly dependent on the size of the 
particles (Zhao et al., 2009).  
 
 
 
 
 
 
 
 
 
36 
 
 
 
2. A SYSTEMATIC APPROACH TO COMPARE THE 
INFLAMMATORY RESPONSE TO INDUCED NANO-SIZED METAL 
COLLOIDS 
 
2.1 Introduction 
 
Research and development efforts in metal and metal oxide 
nanomaterials are providing new opportunities for drug delivery, food packaging, 
cosmetic, and electronic applications that were not possible a few years ago 
(DeWild et al., 2003). However, along with the unique applications of nano-sized 
metals there are also unique cellular interactions at the nano-bio interface due to 
the particle size. Furthermore, because metal materials readily equilibrate in the 
aqueous phase by losing electrons to form cations, nano-sized metal colloids 
could be highly reactive within the engineered application, and could therefore 
pose a potential risk to human health and the environment (Colvin, 2003; 
Carlson et al., 2008).  
Nano-sized metal colloids possess larger surface area and surface free 
energy when compared to micron-scale metals, which may lead to either a 
simulated metal ion response by an intact nanoparticle or an increased 
dissociation of cations from the nanoparticle surface into the surrounding matrix 
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(i.e. water, biological fluid, or cells). Some toxicological evaluations of nano-
sized metal colloids have shown that as nanomaterial dose increases, the 
cellular viability decreases. In particular, (Hussain, et al., 2005) suggested that 
silver nanoparticle-exposed cells became abnormal in size, displayed cellular 
shrinkage, and acquired an irregular shape. The authors concluded that 
exposure to this metal nanoparticle system resulted in cellular oxidative stress 
(Hussain et al., 2005). Other studies have shown that metal nanoparticles cause 
depletion of glutathione, reduced mitochondrial function and metabolic activity, 
and increased accumulation of metal ions (Braydich-Stolle et al., 2005; Hussain 
et al., 2005; Chen et al., 2006; Hussain et al., 2006; Meng et al., 2007; Guo et 
al., 2008; Lei et al., 2008; Midander et al., 2009). All of these toxicological 
observations at the cellular level are indicative of metal ion exposures and 
subsequent induced toxicities (Stohs and Bagchi, 1995; Cortese-Krott et al., 
2009). 
Here, we designed a study that incorporated a systematic approach to 
prepare and characterize the cellular responses after exposure to three different 
nano-sized metal colloids (nano-Ag, nano-Cu, and nano-Ni) over a dose-
response and time-course range. Eventually, these data will aid in the prediction 
of nanomaterial-induced cellular responses using the physicochemical 
properties of the material.  
Liver toxicity plays a vital role in drug and toxicant metabolism. Here, we 
used normal mouse hepatocytes, which represent a suitable model for 
38 
 
characterizing cellular susceptibility to metal toxicity (Safe, 1994; Vial and 
Descotes, 1994; Malik et al., 2000; Jaeschke et al., 2002; Xie and Tian, 2006). 
The liver is one of the most relevant tissues for nanomaterial toxicity from 
intentional medical or cosmetic applications or unintentional occupational 
exposures. While the route of entry for cosmetic application is the dermis and 
the route of entry for occupational exposures is the lung, ultimately, the 
particulate matter that is internalized (in the body) will be metabolized and 
excreted via the liver. Therefore, there is a need to understand nanoparticle 
properties and their effects in the body during the excretion process (Wan et al., 
1991; Pinheiro et al., 1996; Das and Buchner, 2007). Potential nanoparticle-
containing drugs or toxicants will eventually interact with liver tissue during 
excretion processes. Therefore, understanding nanomaterial-induced liver 
toxicity is pertinent to the successful development of metal-based 
nanotechnologies.  
Here in this study we have used AML12 normal murine epithelial liver 
cells which provide a simple and physiologically relevant system. Co-culturing of 
parenchymal hepatocytes with non-parenchymal liver cells (NPC) can enhance 
liver function. The co-culture cell system can be used as bioartificial liver. To 
resolve some of the outstanding toxicity concerns, we need a model that more 
accurately mimics the response of the liver in an ex vivo cell culture system. Co-
cultures of primary hepatocytes and NPC can be used to achieve that 
(Zinchenko, et al., 2006).  
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Although previously published research has shown that cells exposed to 
metal and metal oxide nanoparticles exhibit oxidative stress. The exact 
mechanism relating the oxidative stress and nanoparticle exposure is not well 
understood. Several literature reviews showed that nanoparticles can readily 
translocate across the membrane of many different cell-types (Limbach et al., 
2007; Park et al., 2008). It has been shown earlier that cells exposed to several 
metal-containing nanoparticles can develop oxidative stress. Oxidative stress 
can be quantified by measuring the production of reactive oxygen species (ROS) 
by either the surface of the nanoparticle or by the mitochondria reacting to 
stress. An excess of these reactive molecules can cause cellular damage 
(Hussain et al., 2005; Park et al., 2008; Eom and Choi, 2009). As Limbach et al. 
has previously published, this oxidative stress can also occur through Trojan-
horse type mechanism (Limbach et al., 2007).  
Heat shock proteins (Hsp) have been utilized in determining metal 
toxicities and can be used to measure nano-sized metal toxicities. Hsp are 
molecular chaperones involved in protein folding and translocation (Bimston et 
al., 1998; Urani et al., 2001). Specifically, Hsp70 has been used as a general 
marker for cellular damage by metals (Urani et al., 2001). Arora et al. published 
a series of elegant studies that describe the dose-response relationships and 
induction of apoptosis after exposure to silver nanoparticles (Arora et al., 2008; 
Arora et al., 2009). Our goal was to expand on this work by comparing the dose-
response and inflammatory responses of mammalian cells after exposure to 
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silver, copper, or nickel nanoparticles. Our study had two main objectives: first, 
to characterize and identify similarities in the physicochemical properties of 
nano-Ag, nano-Cu, and nano-Ni. The second objective was to determine the 
cytotoxicity and inflammatory responses of liver culture systems induced by the 
three metal colloids. Based on these results and other ongoing experiments in 
our laboratory, nanoparticle-induced toxicity and production of inflammatory 
biomarkers (on a cellular level) is found to be dependent on size, aggregation 
state, surface charge, and redox chemistry on the nanoparticle surface.  
2.2 Materials and methods 
2.2.1 Preparation and characterization of nano-sized metal colloids 
Commercially manufactured nano-Ag, nano-Cu, and nano-Ni 
nanomaterials (approx. 30 nm) were purchased at 99.5% purity from Sigma-
Aldrich (St. Louis, MO). The stock solutions of each material were prepared in 
Milli-Q ultrapure water. Each stock was then washed in phosphate-buffered 
saline (PBS) and analyzed in cell culture media (Sayes et al., 2007). 
Suspensions were serially diluted from the stock, resulting in concentrations 
from 0.1 to 1000 mg/L. Surface area was measured in the dry state using the 
BET method under N2 absorption on a Micrometrics ASAP 2020 instrument 
(Brunauer et al., 1938; Reddy et al., 2001; Chen et al., 2004). TEM (JEOL 2010, 
JEOL Ltd., Tokyo, Japan) operated at 200 kV was used to determine 
agglomerate size and particle morphology (Wang, 2000). TEM grids were 
prepared by adding 2 µL of nanomaterial suspended in ethanol (100 ppm) onto 
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the copper grid surface (carbon-coated 400 mesh). Dynamic light scattering 
(DLS, Malvern Zetasizer Nano S 1600) was used to measure particle size 
populations and zeta potentials while in the aqueous suspension (Berne and 
Pecora, 1974; Panacek et al., 2006).  
2.2.2 Cell culture conditions 
Murine liver cells AML12 were purchased from American Type Tissue 
Collection (Manassas, VA). Liver cell cultures were plated at equivalent cell 
densities and exposed to the nanomaterial suspensions at 80% confluency. 
Cells were exposed to nano-Ag, nano-Cu, or nano-Ni suspensions and probed 
for cytotoxicity and inflammatory endpoints at 4 h, 24 h, 48 hr, and 1 week. For 
the 1-week time point, cell culture media was exchanged and re-dosed every 
other day. Exposure concentrations included 0.1mg/L, 1.0mg/L, 10mg/L, 
100mg/L, and 1000mg/L concentrations of nanomaterials.  
2.2.3 Isolation and culture of Kupffer’s cells and lymphocytes 
C57BL6 mice (Jackson Laboratory, Bar Harbor, ME) were euthanized 
using CO2 inhalation. Animals were provided humane care according to the 
institutional guidelines (University Laboratory Animal Care Committee, Texas 
A&M University). Following removal from the abdominal cavity, the liver was 
perfused with 30 mL of ice-cold serum-free RPMI 1640 using a peristaltic pump. 
Cells were collected in sterile centrifuge tubes and centrifuged at 300 rpm for 3 
min. The pellet contained the majority of the hepatocytes, while most 
lymphocytes remained in the supernatant. The sample was decanted and 
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centrifuged again for 10 min at 1200 rpm. Both pellets (Kupffer’s cells and 
lymphocytes) were then resuspended in serum-free RPMI 1640 medium (Crispe 
and Mehal, 1996; Mehal et al., 1999). 
Both single cell-type cultures and co-cultures were maintained at 37°C 
with 5% CO2 in Dulbecco’s Modification of Eagle’s Medium: Ham's F12K 
Medium (DMEM:F12K, American Type Tissue Collection (ATCC), Manassas, 
VA) and were supplemented with 10% fetal bovine serum (FBS, ATCC, 
Manassas, VA) and 1% penicillin and streptomycin (Sigma-Aldrich, St. Louis, 
MO) (Wu et al., 1994; Dumenco et al., 1995).  
2.2.4 Analysis of cellular uptake of nanomaterials 
For elemental analyses, inductively coupled plasma-mass spectroscopy 
(ICP-MS, Perkin Elmer DRC 2 spectrometer) was used to determine the identity 
and quantity of free metal ions released into the suspensions over time. 
Samples for ICP-MS were diluted and mildly digested using 5% hydrochloric 
acid and 1% nitric acid by volume (Becker, 2002; Guo et al., 2009). Differential 
interference contrast optical microscopy was also used to evaluate cellular 
uptake of nanomaterials using a Zeiss Stallion DDI workstation with a 63X, C-
Apo 1.2 NA water immersion lens. Optical slices through cells (Z-stacks) were 
recorded in 0.5-µm steps to verify that nanomaterials were on the same plane as 
cytoplasmic organelles. Small aggregates of the nanomaterials exhibited 
movement in the cytoplasm that resembled cytoplasmic organelles, whereas 
those agglomerates adsorbed to the plasma membrane were static. 
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2.2.5. Cytotoxicity assessment 
Cellular viability was measured using three independent techniques. First, 
the colorimetric dye, resazurin (Sigma Aldrich, St. Louis, MO) was used to 
determine the number of viable healthy cells as a function of the metabolism of 
resazurin to its metabolite resorufin (King et al., 1984; Putnam et al., 2002). 
Briefly, after the cultures were incubated with the nanomaterials for 4 h, 48 h, 
and 1 week, cells were removed from the incubator, media was aspirated, and 
the resazurin dye solution was added (10% of original cell culture media). After a 
4 h incubation at 37°C, the samples were gently mixed in a gyratory shaker, and 
the resultant adduct formation was measured spectrophotometrically at a 
wavelength of 600 nm (Dutka et al., 1983). Second, the reduction of MTT (3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) to formazan was 
used as an indicator of metabolic activity and to validate cytotoxicity results 
(Mosmann, 1983) (data not shown). Third, cell counts were measured using a 
Coulter Z1 particle counter (Chadalapaka et al., 2008).   
2.2.6 mRNA extraction and RT-PCR analysis of cytokine and stress protein 
levels  
The interference of nano-sized metal colloids on the production of 
interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and heat shock protein 
70 (Hsp70) mRNA was evaluated. Total RNA was extracted from the 
nanomaterial-exposed liver cell culture systems using the RNeasy Midi kit 
(Quiagen, Valencia, CA) and used for one-step real-time quantitative 
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polymerase chain reaction (RT-PCR) via SYBR Green (Apte et al., 2005). An 
ABI 7500 Real-Time PCR System (Applied Biosystems, Foster City, CA) was 
used to denature the samples at 95°C for 10 min. The thermal cycling step was 
for 40 cycles at 95°C for 15 s, and 40 cycles at 60°C for 1 min. The thermal 
cycling was followed by the dissociation step (95°C for 15 s, at 60°C for 1 min, 
and then 95°C for 15 s). Each reaction mixture contained both forward and 
reverse primers of IL-6 and TNF-α, RNase inhibitor, and Reverse Transcriptase 
in a SYBR Green master mix (Applied Biosystems, Foster City, CA). Primers 
were obtained from IDT (Coralville, IA) and used for amplification. The software 
Primer Express (Applied Biosystems, Foster City, CA) was used to design the 
primers: IL-6 (Forward: 5’-AGT TGC CTT CTT GGG ACT GA-3'; Reverse: 5'-
TCC ACG ATT TCC CAG AGA AC- 3'). TNF-α (Forward: 5'- AGC CCC CAG 
TCT GTA TCC TT-3'; Reverse: 5’-CTC CCT TTG CAG AAC TCA GG-3). Hsp70 
(Forward: 5-CGA GGC TGA CAA GAA GAA-3; Reverse: GGC CTC TAA TCC 
ACC TCC TC). The mRNA levels were normalized using β-actin (Forward: 5'-
CCG TGA AAA GAT GAC CCA GAT-3'; Reverse: 5’-CAC AGC CTG GAT GGC 
TAC GT-3') as an internal housekeeping gene (Chintharlapalli et al., 2007).  
2.2.7 Probe for reactive oxygen species, in vitro 
Reactive oxygen species (ROS) production in the nanomaterial-dosed 
cells was examined intracellularly using 2,7-dichlorodihydrofluorescein 
diacetate (DCF-DA, Sigma, St. Louis, MO. USA) (AshaRani et al., 2009). Briefly, 
colloid-dosed liver cells were washed with PBS and incubated with DCFH-DA for 
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30 mins. The fluorescence of each nanomaterial-exposed sample was 
measured at ex/em 485/520 nm. (Hussain et al., 2005; Park et al., 2008; Eom 
and Choi, 2009).  
2.2.8 Western blot analysis of Hsp70  
Hepatocytes were plated as described above. Cells were washed with 
ice-cold PBS and lysed with high-salt lysis buffer. Lysates were spun at 12,000 x 
g for 15 min at 4°C, and supernatants were collected. The amount of protein 
present was determined using a Nanodrop spectrophotometer (ND-1000, 
Thermo Scientific, Wilmington, Del.). Sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE) with 8% protein gels was used to quantify 
expression of Hsp70. After running the gel, the samples were transferred into 
nitrocellulose membrane. The membranes were blocked with 0.1% Tween and 
6% non fat powdered milk in PBS buffer for 3 h (Apte et al., 2005), followed by 
overnight incubation with Hsp70 rabbit polyclonal primary antibody (Assay 
Designs, Inc, Ann Arbor, MI). The membranes were then washed with PBS and 
0.1% Tween and incubated in HRP-conjugated anti-rabbit secondary antibody. 
-actin was used as an internal control to ensure equal loading of proteins per 
well. The membranes were then washed with TBST for 10 min, incubated with 
chemiluminiscence reagent from Perkin-Elmer for 1 min and exposed using 
Kodak X-OMAT AR autoradiography film (Eastman Kodak, Rochester, NY) 
(Crosby et al., 2000; Apte et al., 2005; Chintharlapalli et al., 2007). 
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2.2.9 Statistical analyses 
Each experimental value was compared to the corresponding control 
value for each time point. One-way ANOVA and Bartlett’s tests were calculated 
for each sampling time. When the F-test from ANOVA was significant, the 
Dunnett’s or Dunn’s test was used to compare means from the control group 
and each of the groups exposed to colloids. Statistical significance of exposed 
cell populations versus unexposed control populations was established as 
p<0.05. Statistical tests were performed with SAS software (SAS Institute Inc, 
Cary, NC) (Sayes et al., 2007). 
2.3 Results and discussion 
2.3.1 Nano-sized metal colloid characterization 
The first step in evaluating nano-sized metal colloid toxicity was focused 
on understanding the physical properties, including surface charge and 
agglomeration dynamics of nano-sized metal colloidal systems. Fig. 1 shows 
DLS sizing patterns and indicating that nano-Ag exhibited a bimodal sizing 
profile with peaks at 30 nm and 122 nm. The size distribution curves did not 
change over time (up to 1 week after preparation of nanomaterial suspensions). 
In contrast, nano-Ni exhibited varying bimodal and, at some time points, 
polymodal sizing profiles over the 0 h to 1 week time period. The particles 
seemed to form agglomerates and then to de-agglomerate throughout the 
analysis periods. Nano-Cu exhibited similar behavior compared to nano-Ag in 
that the sizing profiles remained static from 0 h to 12 h post-exposure. At 48 h, 
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the sizing peak shifted slightly to the right, indicating the formation of larger 
agglomerates. An even larger shift to the right was observed at the 1 week time 
period. Nano-Cu differed from nano-Ag in that the nano-Cu DLS pattern showed 
one peak, where the nano-Ag DLS pattern showed two peaks. 
TEM provided information on the primary particle size (Fig. 10). All three 
particle types had a primary particle size distribution ranging from approximately 
15 nm to 70 nm, with an average particle size of 30 nm. Micrographs of nano-Ag 
particles showed faceted sides, but were irregularly shaped; nano-Ni particles 
were spherical; and nano-Cu particles were irregularly shaped but had ill-defined 
surfaces.  
Surface area was measured based on the density of the metal and used 
to calculate particle size using the formula: D = 6/ (d  A), where D is particle 
average diameter, d is particle density, and A is the measured surface area 
(Sayes et al., 2007). For nano-Ag, the surface area was 4.9 m2/g, the density 
was 10.5 g/cm3 and the resultant calculated size was 116 nm. For nano-Ni, the 
surface area was 4.7 m2/g, the density was 8.9 g/cm3, and the calculated size 
was 143 nm. For the nano-Cu, the surface area of 9.9 m2/g, the density was 8.9 
g/cm3, and the calculated size was 68.1 nm (Table 1). 
Both nanomaterial agglomeration state and cellular uptake are influenced 
by the surface charge of the nanomaterial. Table 1 also reports the differential 
surface charge of nano-Ag, nano-Ni, and nano-Cu at 4 h, 48 h, and 1 week. Zeta 
potential measurements showed a similar pattern for all three nano-sized metal 
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colloidal systems over the 1-week time period, i.e. the zeta potential value 
changed from a more negatively charge to a less negative charge. Nano-Ag 
changed from -45 to -36 to -30 mV; nano-Ni changed from -25 to -8 to 0 mV; and 
nano-Cu changed from -29 to -17 to -15 mV. 
 
 
Table 1. 
Physical properties of the three metal colloidal systems used in this study. The table 
compares the surface area, density, calculated primary particle size, measured 
hydrodynamic diameter at t=0, t=48 h and t=1 week, and zeta potential at t=0, t=48 h 
and t=1 week 
Property  Ag Ni Cu 
Measured size  
from DLS @ t=4h (nm) 122.4 122.4 255 
Measured size  
from DLS @ t=48h (nm) 122.4 1990 396.1 
Measured size  
from DLS @ t=1week (nm) 122.4 190.1 1106 
Zeta potential 
@ t=4 h(mv) -45.2  -25.1  -29.1  
Zeta potential 
@ t=48 h (mv) -36.5  -8 -17.8  
Zeta potential 
@t=1 week (mv) -30.7 -0.8 -15.7 
 
 
Considering particle size and surface charge observations, it was 
hypothesized that charged particle surfaces in aqueous suspensions helps to 
maintain stable nanoagglomerates (i.e. nano-Ag) over time. Nano-Cu and nano-
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Ni particle suspensions demonstrated loss of surface charge and variation of 
aggregate size. 
DLS and TEM
 
Fig. 10. Sizing profiles of nano-Ag, nano-Ni, and nano-Cu. The dynamic light scatter 
plots of each of the three metals are compared with their corresponding transmission 
electron micrographs. 
 
 
2.3.2 Cellular uptake of nano-sized metal colloids 
Two independent methods were used to verify nanomaterial cellular 
uptake: inductively coupled plasma-mass spectroscopy (ICP-MS) and optical 
microscopy. After exposure to each of the nano-sized metal colloids, 
independently, ICP-MS was used to determine the amount of metal (Ag, Ni, or 
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Cu) in parts per million (ppm) concentrations within the spent media, the 
phosphate buffered saline (PBS) solution wash, and the cell lysates. Optical 
microscopy showed evidence of both large and smaller agglomerates inside the 
cell. Taken together, the data indicated that the colloids were taken into the 
cells. However, the exact cellular uptake mechanisms are not well understood. 
ICP-MS analysis demonstrated that all three nanomaterials were taken up into 
the cell as indicated by the concentration of metal in the cell lysates. However, 
there were differing amounts of metal in each sample. The amount of silver in 
nano-Ag exposed cell lysates was 1.6 ppm, the amount of copper in nano-Cu 
exposed cell lysates was 0.123 ppm, and the amount of nickel in nano-Ni 
exposed cell lysates was 4.61 ppm. For cells exposed to nano-Ag and nano-Ni, 
most of the metal is in the cell lysates. But for cells exposed to nano-Cu, most of 
the metal is in the spent media. The optical micrographs indicate the same 
phenomenon. Both small and large agglomerates were seen inside the cells 
exposed to nano-Ag and nano-Ni, but no agglomerates were seen inside the 
cells exposed to nano-Cu. Fig. 11 also includes ICP-MS analyses on two control 
suspensions. First, the cell culture media was analyzed for residual amounts of 
silver, copper, and nickel. The bars in the graphs are labeled as “media”. 
Second, the cell culture media spiked with a 35% v/v suspension of 100 ppm 
nano-Ag, nano-Cu, or nano-Ni was analyzed for silver, copper, and nickel.These 
bars are labeled as “Ag spiked media,” “Cu spiked media,” and “Ni spiked 
media.” 
51 
 
 
Fig 11. Evidence of nano-metal colloid cellular uptake. Endocytosis of nano-Ag, nano-
Cu, and nano-Ni was verified using two independent methods: inductively coupled 
plasma-mass spectroscopy and optical microscopy. AML12 cells were inoculated with 
the different nano-sized metal colloids. All doses are 350 µL of 100 mg/L. Images were 
taken at 36 h post-exposure. Control suspensions include the pristine cell culture media 
(labeled as “media”) and the cell culture media spiked with 35% v/v suspension of 100 
ppm nano-Ag, nano-Cu, or nano-Ni (labeled as “Ag spiked media”, “Cu spiked media”, 
and “Ni spiked media”). Each suspension was analyzed for silver, copper, and nickel 
using ICP-MS.  
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2.3.3 Cytotoxicity and inflammatory responses 
Liver culture cell viability and production of inflammatory cytokine 
biomarkers and stress protein mRNA expression are shown in Fig. 12  to Fig 16. 
For the nano-Ag exposed single cell culture system and co- culture system, no 
significant cell death was observed at the 4 h and 48 h exposure time points. 
Significant decrease in viability was observed at the 1 week time point, relative 
to control cell culture systems. For the nano-Cu exposed single cells culture 
system and co-culture system, significant cell death was observed at all 
exposure time points (Fig. 12 and Fig. 13). For the nano-Ni exposed cells, 
significant cell death was observed at the 4 h and 1 week exposures whereas for 
the nano-Ni exposed co-culture system, no significant cell death was observed 
(Fig.  and Fig. 13). Further, there was a differential decrease in viability among 
the three nanomaterial systems, where nano-Cu decreased viability by 30% at 
the 0.01 mg/L dose (as measured by the metabolism of resazurin dye), nano-Ni 
decreased viability by 25% at the 0.01 mg/L dose, and nano-Ag decreased 
viability by 5% at the 0.01 mg/L dose (Fig. ). Results indicated similar trends 
using the MTT assay for metabolic activity: metabolic activity was decreased the 
most after exposure to nano-Cu, metabolic activity was slight decreased after 
exposure to nano-Ni, and metabolic activity did not decrease, relative to control 
cells, after exposure to nano-Ag (data not shown).  
In contrast to cellular viability, when measured inflammatory cytokine 
biomarker differential responses between the single cell culture system versus 
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the co-culture system, similar results were observed for the two test systems. 
Exposure to nano-Ag did not produce significant increases in TNF-α, IL-6, or 
Hsp70 levels, while exposures to nano-Cu and nano-Ni produced significant 
inflammatory responses (Fig. 14 and Fig. 15) and increased mRNA level of 
stress protein Hsp70 in liver cell line (Fig. 16). 
Generally, toxicological studies show linear or exponential increase in 
response as the dose is increased. But, in nanotoxicology studies, because 
there is a limit to the increase in nanoparticle dose, there is also a limit to the 
increase in nanoparticle relevant response. In the results included in this study, 
as with many data sets published in the literature, nanotoxicity data sets show 
that there is a drop in response after a relatively large nanoparticle dose. This 
effect is probably due to the fact that nanoparticles aggregate or agglomerate 
and do not act as nanoparticles at higher concentrations. 
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Fig. 12. Effect of nano-sized metal colloids on cellular viability in AML12 mice heptocyte 
cultures. Cells were treated with increasing concentrations of nano-Ag, nano-Cu, or 
nano-Ni for 4 h 48 h, and 1 week. (A) Cell cultures were inoculated with nano-Ag, (B) 
cell cultures inoculated with nano-Cu, (C) cell cultures inoculated with nano-Ni. At the 
end of the incubation period, metabolic activity was determined by the production of the 
metabolite resorufin. Absorbance was measured at 595nm. Background absorbance of 
multiwell plates and of nanomaterial spiked cell culture media was subtracted from 
measurement. *p < 0.05 vs. control cell population 
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Fig. 13. Effect of nano-sized metal colloids on cellular viability in co-culture of primary 
Kupffer’s cells, lymphocytes isolated from C57BL6 mice and AML12 mice heptocyte 
cultures. Cells were treated with increasing concentrations of nano-Ag, nano-Cu, or 
nano-Ni for 48 h. (D) Cell cultures were inoculated with nano-Ag, (E) cell cultures 
inoculated with nano-Cu, (F) cell cultures inoculated with nano-Ni. At the end of the 
incubation period, metabolic activity was determined by the production of the metabolite 
resorufin. Absorbance was measured at 595nm. Background absorbance of multiwall 
plates and of nanomaterial spiked cell culture media was subtracted from 
measurement. *p < 0.05 vs. control cell population 
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Fig. 14. Analyses of cytokine messenger RNA levels in AML12. TNF-α and IL-6 mRNA 
detection after exposure to nano-colloid metals by RT-PCR from AML12 hepatocyte 
cultures. (A) Single cell cultures were inoculated with nano-Ag, (B) single cell cultures 
inoculated with nano-Cu, (C) single cell cultures inoculated with nano-Ni. The values 
were normalized with beta actin, the housekeeping gene. *p < 0.05 vs. control cell 
population. 
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Fig. 15. Analyses of cytokine messenger RNA levels in co-culture. TNF-α and IL-6 
mRNA detection after exposure to nano-colloid metals by RT-PCR from co-culture of 
primary Kupffer’s cells, lymphocytes isolated from C57BL6 mice and AML12 mice 
heptocyte cultures (D) Co- culture cells were inoculated with nano-Ag, (E) Co-culture 
cells were inoculated with nano-Cu, (F) co-culture cells were inoculated with nano-Ni. 
The values were normalized with beta actin, the housekeeping gene. *p < 0.05 vs. 
control cell population. 
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Fig. 16. Hsp70 mRNA expression by RT-PCR from AML12 hepatocyte cultures. (A) 
Single cell cultures were inoculated with nano-Ag, (B) single cell cultures inoculated 
with nano-Cu, (C) single cell cultures inoculated with nano-Ni. The values were 
normalized with beta actin. *p < 0.05 vs. control cell population. 
 
 
2.3.4 Cellular stress responses 
Results from western blot analyses of stress protein biomarker 
expression (hsp70), after exposure to nano-Cu, nano-Ni and nano-Ag, showed 
similar trends to the IL-6, TNF-α, and cytotoxicity data sets. Nano-Cu and nano- 
Ni increased hsp70 expression; however, no significant changes were observed 
after exposure to nano-Ag (Fig. 17). 
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The enhanced expression of hsp70 after exposure to nano-Cu and nano-
Ni provided a protection against activation of heat shock factor caused by the 
heavy metals. The mechanism behind these observations is not well 
understood. However, we propose that after exposure to copper and nickel 
nanoparticles, dissociated free metal ions from the particle surface (via the 
intracellular acidification process) enhance expression of hsp70 at sublethal 
concentrations. The increased expression of Hsp70 gene coding for the protein 
after exposure to copper salts has been already shown in many other cell types 
(Urani et al., 2001). 
2.3.5 Production of reactive oxygen species by nano-Ag, nano-Cu and nano-Ni 
The cellular ability to produce ROS was measured by dichlorofluorescin 
diacetate (DCFH-DA) fluorescence. DCFH-DA was hydrolyzed to form 
dichlorofluorescin (DCFH), which remained within the cell. This molecule was 
then oxidized to fluorescent dichlorofluorescin (DCF). Here, DCF fluorescence, 
in copper and nickel exposed cells, increased in a dose-dependent manner as 
compared to the control cell and silver exposed cell populations (Fig.18), 
showed that intracellular ROS production increased in cultures exposed to 100 
and 1000 ppm of nano-Cu and 10, 100, and 1000 ppm of nano-Ni.  
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Fig. 17. Hsp70 protein expression by Western blot analyses in AML12 cells 
dosed with (A) nano-Ag, (B) nano-Ni, and (C) nano-Cu. Graphs below each 
western blot indicates densitometric analysis. -actin was used as an internal 
calibration for these analyses to ensure equivalent protein loading. *p < 0.05 vs. 
control cell population. 
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Fig. 18. Production of ROS in AML12 cells by nanomaterials. The cells were 
dosed with nano-Ag, nano-Cu and nano-Ni for 24 h and of 40 µm of DCFH-DA 
at 37°C for 30 min. The fluorescence in cells was observed using a fluorescence 
plate reader.  
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3. SUMMARY 
Here, we give an explanation for the differential inflammatory response of 
hepatocytes after exposure to nano-Ag, nano-Cu, or nano-Ni. The critical steps 
in nano-sized metal colloid toxicity could include: (1) nanoparticle uptake within 
the cell, (2) nanoparticle releasing free metal ion or dissolution of metal ions 
from the nanomaterial core, and (3) increase in pro-inflammatory cytokinemRNA 
levels. After exposure to a suspension of nano-sized metal colloids, cells in 
culture internalized the particles intracellularly as either small nanoagglomerates 
(90-150 nm) or larger agglomerates (200-500 nm). Silver, copper, or nickel ions 
are leeched from the surface of these agglomerates, either in the cell culture 
media before internalized or within acidified vesicle. The magnitude of charge on 
the surface of the nanoagglomerates is inversely related to the concentration of 
free metal ions in the cell culture media. The concentration of free ions in the 
culture medium contributes to the decrease in cellular viability and induction of 
inflammatory cytokines.  
The inflammatory response of hepatocytes exposed to nano-Cu is not 
due to the nanoparticle exposure alone, but due to a combination of the slight 
cellular uptake of individual nanoparticles (not nanoagglomerates) and 
solubilized copper ions in the culture media. Exposure to copper ions from food, 
through skin or eye contact, or by inhalation of dusts can lead to liver damage 
(Lei et al., 2008). Furthermore,  recent studies suggest that a genetic defect is 
associated with copper poisoning (Johnson, 2008). Intake of copper salts has 
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produced acute copper toxicity in humans and equivalent amounts of copper 
salts are toxic in animals. Ingestion by animals of three ounces of a 1% solution 
of copper ions will produce inflammation of the gastrointestinal tract. When 
copper salts are administered intravenously, as little as 2 mg/kg copper ions are 
lethal to guinea pigs and 4 mg/kg are lethal to rabbits (TOXNET, 1975-1986). 
Exposure to nano-Ag did not decrease cellular viability, nor did nano-Ag 
exposure induce an inflammatory response, supporting earlier observations 
(Ward and Saffle, 1995; Warila et al., 2001; Braydich-Stolle et al., 2005; Harper 
et al., 2006; Singh et al., 2007; Suzuki et al., 2007). Some have speculated that 
because silver does not have a +2 valence state, it does not oxidize into a toxic 
form. We hypothesize that the negatively charged surface on nano-Ag particles 
stabilizes the particle and prohibits ion leeching in cell culture media. Further 
data is needed to address this hypothesis directly. 
We have previously published a mechanism for inducing oxidative stress 
after nanomaterial exposure via acidified cell organelle’s solubilizing water-
insoluble metal oxide particles and hence producing free metal ions (Guo et al., 
2009). In that report, Fe3O4 nanomaterials that released Fe+3 once inside 
acidifed vesicles did not induce oxidative stress. Instead, it was the reductive 
capacity of the engineered carbon black material that reduced Fe+3 to Fe+2, 
resulting in oxidative stress. In the present study, it was determined that cellular 
toxicity was, in part, due to the production of Ni+2 and Cu+2 ions from nano-Ni 
and nano-Cu surfaces in the culture media and/or inside of the cell. However, a 
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combination of nanomaterial physicochemical properties might exist that either 
increases or decreases their biological impact.  
The present study investigated the induction of inflammatory response to 
ROS-producing nano-sized metal colloids. The surface properties, specifically 
the increasingly neutral surface charge of nano-Cu and nano-Ni, are 
hypothesized to be influential factors in nanoparticle-induced cytotoxicity, 
production of inflammatory cytokines, and may be responsible for the 
intracellularly produced reactive oxygen species. In contrast, nano-Ag maintains 
a large negative surface charge over time and little intracellular production of 
ROS is observed in dosed cells. 
In conclusion, results showed predicting nanomaterial toxicities based on 
identifying trends in physical and chemical properties has the potential to aid in 
the development of nanomaterial environmental health and safety assessments. 
In these studies, the following relations were established: nano-Cu particles 
formed small agglomerates, maintained little surface charge, induced 
inflammation, but did not decrease cellular viability; nano-Ni formed large 
agglomerates, lost its surface charge, induced inflammation and decreased 
cellular viability; and nano-Ag particles remained individual particles, also formed 
small agglomerates, maintained charged surfaces, and did not induce 
inflammation or decrease cellular viability.  
In summary, our studies show that nano-Ag, Nano-Cu and nano-Ni all the 
three nano- sized metal colloids internalize inside the liver cells. But among the 
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three different metal colloids, nano-Ag appeared to be less toxic with less 
reactive oxygen species (ROS) production and with little significant changes in 
the pro-inflammatory cytokine expression than the other two metal colloids. 
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